At the Forefront of Drug Innovation With Pfizer
Pfizer uses innovative technology to deliver medicines to people faster. Using simulation can help the company reduce clinical trial times, manufacturing, and time to market. These technologies are creating the next generation of medicine for the diseases that affect us most.
“At Pfizer, we envision a future where simulations are our guiding stars, illuminating the path to groundbreaking therapies, accelerating drug discovery, and revolutionizing patient care through precise, data-driven insights that transform possibilities into realities,” says Dr. Morgan Harris, MSAT CFD group lead at Pfizer. To read the full article, visit ansys.com
